| VKTX Snapshot | |
|---|---|
| Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. The company is headquartered in San Diego, California. | |
| VALUATION DATA | |
| Market Capitalization | $7,037,419,000 | Price to Sales | 0.00 |
| Earnings per Share | $-0.9100 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $64.9300 |
| 52 Week High | $- |
| 52 Week Low | $21.71 |
| 50-Day Moving Average | $- |
| 200-Day Moving Average | $-71.64 |
| All data are from Alpha Vantage as of today. For more infomation on VKTX see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search